Inventor · disambiguated record
John W. Shell
Also filed as: SHELL JOHN W
23 granted patents·3 pending applications·3,793 citations·filing 1974–2012
98Inventor score
Top patents by PatentIndex Score
26 records- 0198US6635280B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Granted Oct 21, 2003·282 cites·70 claims
- 0298US6340475B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 1999·Granted Jan 22, 2002·519 cites·89 claims
- 0398US5972389AGastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matterDEPOMED INC·Filed 1996·Granted Oct 26, 1999·456 cites·33 claims
- 0498US5582837AAlkyl-substituted cellulose-based sustained-release oral drug dosage formsDEPOMED INC·Filed 1995·Granted Dec 10, 1996·314 cites·34 claims
- 0597US4304765AOcular insert housing steroid in two different therapeutic formsALZA CORP·Filed 1980·Granted Dec 8, 1981·220 cites·12 claims
- 0697US3995635AOcular insertALZA CORP·Filed 1974·Granted Dec 7, 1976·159 cites·13 claims
- 0797US3960150ABioerodible ocular deviceALZA CORP·Filed 1975·Granted Jun 1, 1976·199 cites·14 claims
- 0896US7976870B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2004·Granted Jul 12, 2011·82 cites·23 claims
- 0996US5007790ASustained-release oral drug dosage formDEPOMED SYSTEMS INC·Filed 1989·Granted Apr 16, 1991·465 cites·9 claims
- 1096US4478818AOcular preparation housing steroid in two different therapeutic formsALZA CORP·Filed 1984·Granted Oct 23, 1984·186 cites·6 claims
- 1192US4303637AMedication indicated for ocular hypertensionALZA CORP·Filed 1980·Granted Dec 1, 1981·112 cites·24 claims
- 1291US9980903B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractBERNER BRET·Filed 2011·Granted May 29, 2018·14 cites·13 claims
- 1391US7405238B2Pharmacological inducement of the fed mode for enhanced drug administration to the stomachDEPOMED INC·Filed 2002·Granted Jul 29, 2008·36 cites·5 claims
- 1491US4281654ADrug delivery system for controlled ocular therapyALZA CORP·Filed 1980·Granted Aug 4, 1981·178 cites·23 claims
- 1590US4001388AOphthalmological bioerodible drug dispensing formulationALZA CORP·Filed 1975·Granted Jan 4, 1977·70 cites·5 claims
- 1688US4432964ATopical composition containing steroid in two forms released independently from polymeric carrierALZA CORP·Filed 1982·Granted Feb 21, 1984·72 cites·1 claims
- 1788US3986510ABioerodible ocular deviceALZA CORP·Filed 1975·Granted Oct 19, 1976·142 cites·5 claims
- 1886US4115544AOcular system made of bioerodible esters having linear etherALZA CORP·Filed 1977·Granted Sep 19, 1978·50 cites·4 claims
- 1986US3981303ABioerodible ocular deviceALZA CORP·Filed 1975·Granted Sep 21, 1976·51 cites·22 claims
- 2085US3993071ABioerodible ocular deviceALZA CORP·Filed 1975·Granted Nov 23, 1976·118 cites·11 claims
- 2163US5011843ATreatment of glaucoma using phosphodiesterase inhibitorsIOLAB CORP·Filed 1990·Granted Apr 30, 1991·28 cites·2 claims
- 2255US4173226ADevice for administering solid drug particles to an eyeALZA CORP·Filed 1978·Granted Nov 6, 1979·33 cites·3 claims
- 2355US2013149379A1Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2012·Application pending·0 cites
- 2453US2002051820A1Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Application pending·0 cites
- 2543US2002132758A1Method for identifying compounds to treat medical pathologies associated with molecular crystallizationFiled 2002·Application pending·0 cites
- 2641US4975428ATreatment of glaucoma using phosphodiesterase inhibitorsIOLAB CORP·Filed 1988·Granted Dec 4, 1990·7 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →